Shares of veterinary diagnostics manufacturer IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) contributed to the third quarter performance. The company reported strong second quarter results that demonstrated share gains in instruments and reference labs, and assuaged concerns regarding its competitive position in rapid assays. Catalyst placements grew 44% in the quarter, driven by the launch of CatalystOne in the U.S. and Europe. Premium hematology placements grew 30% in the third quarter, a meaningful increase from 14% in the second quarter. Reference lab results were also strong, growing 12.1% in the third quarter. (Neal Rosenberg)
From Baron Funds' Baron Partners Fund shareholder letter for Q3 2015.
Read More:
- How to Pick Value Stocks
- Chuck Royce Reduces Position in Universal Stainless & Alloy Products
- Baron Funds Comments on Douglas Emmett
- Ron Baron Undervalued Stocks
- Ron Baron Top Growth Companies
- Ron Baron High Yield stocks
- Ron Baron Undervalued Stocks
- Ron Baron Top Growth Companies
- Ron Baron High Yield stocks
- Ron Baron Undervalued Stocks
- Ron Baron Top Growth Companies
- Ron Baron High Yield stocks
- Ron Baron Undervalued Stocks
- Ron Baron Top Growth Companies
- Ron Baron High Yield stocks
- Ron Baron Undervalued Stocks
- Ron Baron Top Growth Companies
- Ron Baron High Yield stocks
About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .
This article first appeared on GuruFocus .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
